Canaan XI L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Tyra Biosciences, Inc. COMMON STOCK, $0.0001 PAR VALUE PER SHARE (TYRA)

Filing Manager
Canaan XI L.P.
Reporting Manager
Canaan XI L.P.
Security
Tyra Biosciences, Inc. COMMON STOCK, $0.0001 PAR VALUE PER SHARE
Symbol
TYRA
Shares outstanding
53,280,800 shares
Disclosed Ownership
2,930,444 shares
Ownership
5.5%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 16:15:02 UTC
Date of event
31 Dec 2025
Previous filing
21 Jan 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Canaan XI L.P. 5.5% 2,930,444 2,930,444 0 /s/ Nancy Levenson Nancy Levenson, Attorney-in-Fact
Canaan Partners XI LLC 5.5% 2,930,444 2,930,444 0 /s/ Nancy Levenson Nancy Levenson, Attorney-in-Fact
Canaan 2020+ Co-Investment L.P. - Series 7 0.8% 443,885 443,885 0 /s/ Nancy Levenson Nancy Levenson, Attorney-in-Fact
Canaan Partners 2020+ Co-Investment LLC 0.8% 443,885 443,885 0 /s/ Nancy Levenson Nancy Levenson, Attorney-in-Fact